How SPRAVATO Helps Adults With Treatment-Resistant Depression

by Marpa Minds

SPRAVATO® (esketamine) is an FDA-approved nasal spray prescribed for eligible adults living with treatment-resistant depression. In this video, Marpa Minds explains how SPRAVATO® differs from conventional antidepressants, who may be eligible, and what patients can expect throughout the treatment process. If you've tried multiple antidepressants without achieving meaningful improvement, learning about advanced treatment options can be an important step toward informed care.